Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia∗∗See Appendix for list of principal investigators, study sites, and laboratory sites.
- 1 September 1998
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 82 (6) , 737-743
- https://doi.org/10.1016/s0002-9149(98)00448-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Diet and drug therapy for lipoprotein (a)Current Opinion in Lipidology, 1995
- Evaluation of effects of unmodified niacin on fasting and postprandial plasma lipids in normolipidemic men with hypoalphalipoproteinemiaThe American Journal of Medicine, 1994
- Efficacy and Safety of Controlled-Release Niacin in Dyslipoproteinemic VeteransAnnals of Internal Medicine, 1994
- Hepatic toxicity of unmodified and time-release preparations of niacinThe American Journal of Medicine, 1992
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BNew England Journal of Medicine, 1990
- Effect of Low-Dose Niacin on High-Density Lipoprotein Cholesterol and Total Cholesterol/High-Density Lipoprotein Cholesterol RatioArchives of internal medicine (1960), 1988
- Reduction of Mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by Combined Treatment with Clofibrate and Nicotinic AcidActa Medica Scandinavica, 1988
- Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacinJournal of the American College of Cardiology, 1986
- Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: Clues to mechanism of action of niacinMetabolism, 1985
- Clofibrate and Niacin in Coronary Heart DiseaseJAMA, 1975